ADTX
ADTX
NASDAQ · Biotechnology

Aditxt Inc

$1.30
+0.05 (+4.00%)
As of Mar 22, 11:06 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +938.5% upside
Low Target $9.80
Average Target $13.50
High Target $19.20
Current Price $1.30
Current
$1.30
Target
$13.50
$9.80 $13.50 avg $19.20
Scenario Analysis
Bear Case
$9.80
653.8%
Low target
Base Case
$13.50
+938.5%
Avg target
Bull Case
$19.20
+1,376.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
Target vs 52W High
$13.50
-99.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%